Spire Healthcare Group (LON:SPI) Trading Down 13.8% – Should You Sell?

Shares of Spire Healthcare Group plc (LON:SPI) traded down 13.8% during trading on Wednesday . The company traded as low as GBX 188.60 and last traded at GBX 192.60. 25,558,791 shares changed hands during trading, an increase of 1,567% from the average session volume of 1,533,023 shares. The stock had previously closed at GBX 223.50.

Analysts Set New Price Targets

Separately, JPMorgan Chase & Co. decreased their price target on Spire Healthcare Group from GBX 309 to GBX 303 and set an “overweight” rating on the stock in a research note on Tuesday, August 5th. Three analysts have rated the stock with a Buy rating, According to MarketBeat, the stock has a consensus rating of “Buy” and an average target price of GBX 294.33.

Spire Healthcare Group Trading Down 14.1%

The business’s 50-day moving average price is GBX 234.27 and its two-hundred day moving average price is GBX 222.02. The company has a debt-to-equity ratio of 62.25, a current ratio of 0.70 and a quick ratio of 0.74. The firm has a market cap of £772.38 million, a price-to-earnings ratio of 41.73, a price-to-earnings-growth ratio of 1.06 and a beta of 0.96.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.